A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...

The Rays will get a glimpse of their future in Spring Training. And that future may not be far away. The Rays announced on ...

Explore high-paying leadership roles beyond the C-suite, from senior executives to mid-management, with insights on salaries, ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

The 'Basketball Wives LA' star and influencer has been protective of her youngest child with Houston Rockets star guard Jalen ...

Pitchers and catchers will report to Spring Training for the Seattle Mariners on Feb. 12. And the team recently announced the ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

The Milton Hershey boys wrestling team defeated Lebanon, 55-12, Wednesday night in a non-conference dual meet. Thanks for ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

India's unemployment rate for those 15+ fell from 6% in 2017-18 to 3.2% in 2023-24; urban joblessness dropped from 6.6% in ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...